Amgen (AMGN) and GSK (GSK) will be added to TrumpRx.gov, expanding the list of discounted prescription drugs to 54 medications from six companies, Fox Business reported Monday.

Amgen will cut Amjevita 80% to $299 and discount Aimovig and Repatha by 62%, according to the report. GSK will discount Incruse by 62% to $159 and offer Arnuity, Relenza, and Anoro at 10-51% discounts, the report said.

White House spokesman Kush Desai told the publication that the move furthers President Trump's drug affordability push, promising lower costs and greater transparency.

Amgen, GSK did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)